Stimulation of brain AMP-activated protein kinase attenuates inflammation and acute lung injury in sepsis

Molecular Medicine

Volumn 21, Issue , 2015, Pages 637-644

  Mulchandani, Nikhil ^a   Yang, Weng Lang ^a,b   Khan, Mohammad Moshahid ^b   Zhang, Fangming ^b   Marambaud, Philippe ^b   Nicastro, Jeffrey ^a   Coppa, Gene F ^a   Wang, Ping ^a,b  

^a DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ASPARTATE AMINOTRANSFERASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 2; MYELOPEROXIDASE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 5 AMINO 4 IMIDAZOLECARBOXAMIDE; AICA RIBONUCLEOTIDE; RIBONUCLEOTIDE;

ACUTE LUNG INJURY; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BRAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HISTOPATHOLOGY; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEPSIS; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; CELL SURVIVAL; DRUG EFFECTS; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INFLAMMATION; METABOLISM; PATHOLOGY; PHOSPHORYLATION;

ACUTE LUNG INJURY; AMINOIMIDAZOLE CARBOXAMIDE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BRAIN; CELL SURVIVAL; ENERGY METABOLISM; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; MALE; MICE; PHOSPHORYLATION; RIBONUCLEOTIDES; SEPSIS;

EID: 84948767733     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2015.00179     Document Type: Article

References (56)

1. Gaieski DF, Edwards JM, Kallan MJ, Carr BG. (2013) Benchmarking the incidence and mortality of severe sepsis in the United States. Crit. Care Med. 41:1167-74.
2. Khan MM, Yang WL, Wang P. (2015) Endoplasmic reticulum stress in sepsis. Shock. 44:294-304.
3. Hu Z, et al. (2015) Ursolic acid improves survival and attenuates lung injury in septic rats induced by cecal ligation and puncture. J. Surg. Res. 194:528-36.
4. Sharma A, Matsuo S, Yang WL, Wang Z, Wang P. (2014) Receptor-interacting protein kinase 3 deficiency inhibits immune cell infiltration and attenuates organ injury in sepsis. Crit. Care. 18:R142.
5. Neumann B, et al. (1999) Mechanisms of acute inflammatory lung injury induced by abdominal sepsis. Int. Immunol. 11:217-27.
6. Ayala A, et al. (2002) Shock-induced neutrophil mediated priming for acute lung injury in mice: divergent effects of TLR-4 and TLR-4/FasL deficiency. Am. J. Pathol. 161:2283-94.
7. Lomas-Neira JL, Chung CS, Wesche DE, Perl M, Ayala A. (2005) In vivo gene silencing (with siRNA) of pulmonary expression of MIP-2 versus KC results in divergent effects on hemorrhage- induced, neutrophil-mediated septic acute lung injury. J. Leukoc. Biol. 77:846-53.
8. Filgueiras LR, Capelozzi VL, Martins JO, Jancar S. (2014) Sepsis-induced lung inflammation is modulated by insulin. BMC Pulm. Med. 14:177.
9. Mannam P, et al. (2014) MKK3 regulates mitochondrial biogenesis and mitophagy in sepsisinduced lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 306:L604-19.
10. Aziz M, Jacob A, Yang WL, Matsuda A, Wang P. (2013) Current trends in inflammatory and immunomodulatory mediators in sepsis. J. Leukoc. Biol. 93:329-42.
11. Botha AJ, et al. (1995) Early neutrophil sequestration after injury: a pathogenic mechanism for multiple organ failure. J. Trauma. 39:411-7.
12. Hardie DG. (2003) Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology. 144:5179-83.
13. Zhao X, et al. (2008) Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 295:L497-504.
14. Viollet B, et al. (2003) The AMP-activated protein kinase alpha2 catalytic subunit controls wholebody insulin sensitivity. J. Clin. Invest. 111:91-8.
15. Mihaylova MM, Shaw RJ. (2011) The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat. Cell Biol. 13:1016-23.
16. Li XN, et al. (2009) Activation of the AMPKFOXO3 pathway reduces fatty acid-induced increase in intracellular reactive oxygen species by upregulating thioredoxin. Diabetes. 58:2246-57.
17. Dolinsky VW, Dyck JR. (2006) Role of AMP- activated protein kinase in healthy and diseased hearts. Am. J. Physiol. Heart Circ. Physiol. 291: H2557-69.
18. Salminen A, Hyttinen JM, Kaarniranta K. (2011) AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan. J. Mol. Med. (Berl). 89:667-76.
19. Sullivan JE, et al. (1994) Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase. FEBS Lett. 353:33-6.
20. Bai A, et al. (2010) AMPK agonist downregulates innate and adaptive immune responses in TNBSinduced murine acute and relapsing colitis. Biochem. Pharmacol. 80:1708-17.
21. Hoogendijk AJ, Pinhancos SS, van der Poll T, Wieland CW. (2013) AMP-activated protein kinase activation by 5-aminoimidazole-4-carbox-amide-1- beta-D-ribofuranoside (AICAR) reduces lipoteichoic acid-induced lung inflammation. J. Biol. Chem. 288:7047-52.
22. Giri S, et al. (2004) 5-aminoimidazole-4-carboxamide- 1-beta-4-ribofuranoside inhibits proinflammatory response in glial cells: a possible role of AMP-activated protein kinase. J. Neurosci. 24:479-87.
23. Tracey KJ. (2007) Physiology and immunology of the cholinergic antiinflammatory pathway. J. Clin. Invest. 117:289-96.
24. Huston JM, et al. (2007) Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis. Crit. Care Med. 35:2762-8.
25. Boeckxstaens G. (2013) The clinical importance of the anti-inflammatory vagovagal reflex. Handb. Clin. Neurol. 117:119-34.
26. Park J, Kang JW, Lee SM. (2013) Activation of the cholinergic anti-inflammatory pathway by nicotine attenuates hepatic ischemia/reperfusion injury via heme oxygenase-1 induction. Eur. J. Pharmacol. 707:61-70.
27. Cai D, Liu T. (2011) Hypothalamic inflammation: a double-edged sword to nutritional diseases. Ann. N. Y. Acad. Sci. 1243:E1-39.
28. Ronnett GV, Aja S. (2008) AMP-activated protein kinase in the brain. Int. J. Obes. (Lond). 32 Suppl 4: S42-8.
29. Turnley AM, et al. (1999) Cellular distribution and developmental expression of AMP-activated protein kinase isoforms in mouse central nervous system. J. Neurochem. 72:1707-16.
30. Amato S, Man HY. (2011) Bioenergy sensing in the brain: the role of AMP-activated protein kinase in neuronal metabolism, development and neurological diseases. Cell Cycle. 10:3452-60.
31. Giangola MD, et al. (2013) Growth arrest-specific protein 6 attenuates neutrophil migration and acute lung injury in sepsis. Shock. 40:485-91.
32. Hirano Y, et al. (2015) Neutralization of osteopontin attenuates neutrophil migration in sepsisinduced acute lung injury. Crit. Care. 19:782.
33. Hudson LD. (1995) New therapies for ARDS. Chest. 108:79S-91S.
34. Oberholzer C, Oberholzer A, Clare-Salzler M, Moldawer LL. (2001) Apoptosis in sepsis: a new target for therapeutic exploration. FASEB J. 15:879-92.
35. Liu D, Zienkiewicz J, DiGiandomenico A, Hawiger J. (2009) Suppression of acute lung inflammation by intracellular peptide delivery of a nuclear import inhibitor. Mol. Ther. 17:796-802.
36. Schmal H, Shanley TP, Jones ML, Friedl HP, Ward PA. (1996) Role for macrophage inflammatory protein-2 in lipopolysaccharide-induced lung injury in rats. J. Immunol. 156:1963-72.
37. Lomas JL, et al. (2003) Differential effects of macro - phage inflammatory chemokine-2 and keratinocytederived chemokine on hemorrhage-induced neutrophil priming for lung inflammation: assessment by adoptive cells transfer in mice. Shock. 19:358-65.
38. Chong DL, Sriskandan S. (2011) Pro-inflammatory mechanisms in sepsis. Contrib. Microbiol. 17:86-107.
39. Escobar DA, et al. (2015) Adenosine monophosphate- activated protein kinase activation protects against sepsis-induced organ injury and inflammation. J. Surg. Res. 194:262-72.
40. Torgersen C, et al. (2009) Macroscopic postmortem findings in 235 surgical intensive care patients with sepsis. Anesth. Analg. 108:1841-7.
41. Weiss YG, et al. (2001) Adenoviral vector transfection into the pulmonary epithelium after cecal ligation and puncture in rats. Anesthesiology. 95:974-82.
42. Aschkenasy G, Bromberg Z, Raj N, Deutschman CS, Weiss YG. (2011) Enhanced Hsp70 expression protects against acute lung injury by modulating apoptotic pathways. PLoS One. 6:e26956.
43. Chopra M, Reuben JS, Sharma AC. (2009) Acute lung injury: apoptosis and signaling mechanisms. Exp. Biol. Med. (Maywood). 234:361-71.
44. Kim JE, et al. (2008) AMPK activator, AICAR, inhibits palmitate-induced apoptosis in osteoblast. Bone. 43:394-404.
45. Rossi A, Lord JM. (2013) Adiponectin inhibits neutrophil apoptosis via activation of AMP kinase, PKB and ERK 1/2 MAP kinase. Apoptosis. 18:1469-80.
46. Kim J, Park YJ, Jang Y, Kwon YH. (2011) AMPK activation inhibits apoptosis and tau hyperphosphorylation mediated by palmitate in SH-SY5Y cells. Brain Res. 1418:42-51.
47. Shanley TP, et al. (1997) Requirement for C-X-C chemokines (macrophage inflammatory protein- 2 and cytokine-induced neutrophil chemoattractant) in IgG immune complex-induced lung injury. J. Immunol. 158:3439-48.
48. Schmekel B, et al. (1990) Myeloperoxidase in human lung lavage. I. A marker of local neutrophil activity. Inflammation. 14:447-54.
49. Bellinger DL, et al. (2008) Sympathetic modulation of immunity: relevance to disease. Cell Immunol. 252:27-56.
50. Cervi AL, Lukewich MK, Lomax AE. (2014) Neural regulation of gastrointestinal inflammation: role of the sympathetic nervous system. Auton. Neurosci. 182:83-8.
51. Huston JM. (2012) The vagus nerve and the inflammatory reflex: wandering on a new treatment paradigm for systemic inflammation and sepsis. Surg. Infect. (Larchmt). 13:187-93.
52. Ji H, et al. (2014) Central cholinergic activation of a vagus nerve-to-spleen circuit alleviates experimental colitis. Mucosal Immunol. 7:335-47.
53. Smith SM, Vale WW. (2006) The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin. Neurosci. 8:383-95.
54. Silverman MN, Pearce BD, Biron CA, Miller AH. (2005) Immune modulation of the hypothalamicpituitary- adrenal (HPA) axis during viral infection. Viral Immunol. 18:41-78.
55. Bernik TR, et al. (2002) Pharmacological stimulation of the cholinergic antiinflammatory pathway. J. Exp. Med. 195:781-8.
56. Santos GA, et al. (2013) Hypothalamic AMPK activation blocks lipopolysaccharide inhibition of glucose production in mice liver. Mol. Cell. Endocrinol. 381:88-96.